Jaskaran Singh
Impact in
- Biological Psychiatry top 0.02%
- Tryptophan and brain disorders
- Pharmacology top 0.02%
- Treatment of Major Depression
Papers in
- Pharmacology 55
- Treatment of Major Depression 55
-
- Bipolar Disorder and Treatment 11
- Schizophrenia research and treatment 9
- Co-authors
- Husseini K. Manji (25 shared papers)Carlos A. Zarate (12 shared papers)David A. Luckenbaugh (6 shared papers)Dennis S. Charney (4 shared papers)Paul J. Carlson (3 shared papers)Rezvan Ameli (1 shared paper)Nancy E. Brutsché (1 shared paper)Wayne C. Drevets (40 shared papers)
- Journals
- Biological Psychiatry (8 papers)The International Journal of Neuropsychopharmacology (7 papers)European Neuropsychopharmacology (5 papers)American Journal of Geriatric Psychiatry (5 papers)American Journal of Psychiatry (4 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Jaskaran Singh
90 papers receiving 8.2k citations
Jaskaran Singh's Hit Papers
Peers
Comparison fields: 5 of 111
- Biological Psychiatry 3.0k
- Pharmacology 4.9k
- Behavioral Neuroscience 607
- Psychiatry and Mental health 1.6k
- Cellular and Molecular Neuroscience 2.1k
Countries citing papers authored by Jaskaran Singh
This map shows the geographic impact of Jaskaran Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaskaran Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaskaran Singh more than expected).
Fields of papers citing papers by Jaskaran Singh
This network shows the impact of papers produced by Jaskaran Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaskaran Singh. The network helps show where Jaskaran Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaskaran Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Hit paper breakdown → | 2006 | 2733 |
| 2 | Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression Hit paper breakdown → | 2017 | 511 |
| 3 | Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study Hit paper breakdown → | 2019 | 507 |
| 4 | A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression Hit paper breakdown → | 2016 | 386 |
| 5 | Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study Hit paper breakdown → | 2018 | 371 |
| 6 | Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study Hit paper breakdown → | 2015 | 334 |
| 7 | Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1) Hit paper breakdown → | 2019 | 318 |
| 8 | 2006 | 316 | |
| 9 | 2004 | 246 | |
| 10 | Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3 Hit paper breakdown → | 2019 | 232 |
| 11 | 2006 | 206 | |
| 12 | 2005 | 194 | |
| 13 | 2004 | 187 | |
| 14 | 2007 | 144 | |
| 15 | 2006 | 117 | |
| 16 | 2006 | 101 | |
| 17 | 2012 | 87 | |
| 18 | 2016 | 80 | |
| 19 | 2017 | 77 | |
| 20 | 2012 | 71 |
About Jaskaran Singh
Jaskaran Singh is a scholar working on Pharmacology, Psychiatry and Mental health, Biological Psychiatry, Experimental and Cognitive Psychology and Sensory Systems, having authored 95 papers that have together received 8.4k indexed citations. Recurring topics across this work include Treatment of Major Depression (55 papers), Tryptophan and brain disorders (15 papers), Bipolar Disorder and Treatment (11 papers), Schizophrenia research and treatment (9 papers), Olfactory and Sensory Function Studies (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers), Neuroscience and Neuropharmacology Research (3 papers) and Mental Health Research Topics (3 papers). The work is most often cited by research in Biological Psychiatry (3.0k citations), Pharmacology (4.9k citations), Behavioral Neuroscience (607 citations), Psychiatry and Mental health (1.6k citations) and Cellular and Molecular Neuroscience (2.1k citations). Jaskaran Singh has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Husseini K. Manji, Carlos A. Zarate, David A. Luckenbaugh, Dennis S. Charney, Paul J. Carlson, Rezvan Ameli, Nancy E. Brutsché, Wayne C. Drevets, Ella Daly and Pilar Lim. Their work appears in journals such as Biological Psychiatry, The International Journal of Neuropsychopharmacology, European Neuropsychopharmacology, American Journal of Geriatric Psychiatry and American Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.